Skip to main content
  • Login
  • Contact
  • Subscribe
  • Advertise With Us

Search form

Home

The Pilot News

Plymouth weather info

  • Home
    • Forms
  • News
    • Local News
    • The Leader of Starke County
    • Culver Citizen
    • Business News
  • Sports
  • Obituaries
  • Classifieds
    • Place an Ad
    • Classified Display Ads
  • Entertainment
    • Calendar
    • Best Of
    • Special Sections
    • Talking About...
    • Games
  • Photos
  • Videos
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Direxion S&P Biotech Bull 3X (NY: LABU)
35.70 USD  -3.18 (-8.18%)
Official Closing Price  /  Updated: 8:00 PM EDT, Aug 23, 2019  /  Add to My Watchlist      
View: Quote
Overview
Charting
Historical Prices
 News
All News
Press Releases
Related Stories
Blogs
Podcasts
Fund Overview
Direxion S&P Biotech Bull 3X
Sector
Exchange Traded NY
Net Assets 153.92M
Inception Date
Related Funds
Quote
Price 35.70
Volume 3,892,100
Last Trade Aug 23, 8:00pm
Change (%)
-3.18 (-8.18%)
Prev. Close 38.88
YTD %
+4.45%
Dividend Yield 0.32%
Performance
YTD
+1.52 (4.45%)
1 Month
-11.10 (-23.72%)
3 Month
-7.91 (-18.14%)
6 Month
-17.15 (-32.45%)
1 Year
-59.17 (-62.37%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Sell on the Pop Prospects: July 24 Edition
July 24, 2019
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to... Read More
from ETFdb
Trading Eye For The Rate-Cut Guy
July 22, 2019
If monetary policy hawks were hoping to get a reprieve from the rising sentiment of an upcoming rate cut, Jerome Powell’s ... Read More
from Benzinga
Top News
More News
Sell on the Pop Prospects: June 26 Edition
June 26, 2019
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to... Read More
from ETFdb
A Beloved Biotech ETF Could Lure Traders Again
June 19, 2019
With biotechnology stocks and the related exchange-traded funds recently showing some signs of life, it could be just a matter of time ... Read More
from Benzinga
A Big Week for Betting On the CURE for Cancer
June 08, 2019
One of the biggest healthcare conferences of the year just ended—the American Society of Clinical Oncology Annual Meeting. Since ASCO was founded in 1964, funding for cancer research has gone from less... Read More
from ETF Trends
It's Time To Consider Leveraged Healthcare ETFs
June 07, 2019
For traders using leveraged sector exchange-traded funds, one key to successfully using these products in the short-term fashion in which they are intended is to treat leveraged ETFs as event-driven... Read More
from Blogs - TalkMarkets
It's Time To Consider Leveraged Healthcare ETFs
June 07, 2019
For traders using leveraged sector exchange-traded funds, one key to successfully using these products in the short-term fashion in ... Read More
from Benzinga
A Big Week for Betting On the CURE for Cancer
June 06, 2019
By Direxion One of the biggest healthcare conferences of the year just ended—the American Society of Clinical Oncology Annual Meeting. Since ASCO was founded in 1964, funding for cancer research has... Read More
from ETFdb
5 Leveraged ETFs With Biggest 1-Month Fund Flows
May 22, 2019
For the past month, leveraged exchange-traded fund (ETF) traders have been feasting off opportunities in gold, biotech, large caps, and semiconductors as the U.S.-China trade deal went awry. The flight... Read More
from ETF Trends
Stock ETFs Outpace Bond ETF Interest By $18B April
May 06, 2019
Equity markets have been on a tear since the beginning of the year, and ETFs are reflecting this trend, with Equity ETF inflows outpacing bond ETFs by $18 billion in April alone. While many have... Read More
from ETF Trends
5 Best-Performing Leveraged ETFs Year-to-Date
April 15, 2019
As the first quarter of 2019 drew to a close, leveraged ETF traders saw oil and technology take the top spots for year-to-date gainers. 2019 started off strong for U.S. equities–the Dow Jones... Read More
from ETFdb
Big Moves In Leveraged Biotech ETFs
April 09, 2019
Leveraged biotechnology exchange traded funds (ETFs) are known to make big moves, but sometimes those moves are not always about price ... Read More
from Benzinga
Swing Trading Review
April 06, 2019
This week we discuss our profitable swing trades of NUGT and EDC. Both of these trades are volatile swing trades using leveraged ETF’s. Read More
from Blogs - TalkMarkets
6 Best Performing Leveraged ETFs Of Q1
March 30, 2019
For ETF investors who are bullish on U.S. equities for the near term, any of these products could make an interesting choice. Read More
from Blogs - TalkMarkets
5 Best-Performing Leveraged ETFs Year-to-Date
March 29, 2019
As the first quarter of 2019 draws to a close, leveraged exchange-traded fund (ETF) traders have seen oil and technology take the top spots for year-to-date gainers. 2019 started off strong for U.S.... Read More
from ETF Trends
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2019 The Pilot News | 214 N. Michigan | Plymouth, IN 46563 | (574) 936-3101 • 800-933-0356
All property rights for the entire contents of this publication shall be the property of The Pilot News.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media